| Company type | Private |
|---|---|
| Industry | Private Equity & Venture Capital |
| Founded | (1996) |
| Headquarters | São Paulo, Brazil |
Key people | Paulo Henrique de Oliveira Santos, (CEO) |
| Products | Investment company |
Number of employees | 25,700[citation needed] |
| Parent | Votorantim Group |
| Website | www.vventures.com.br |
VNN is a venture capital and private equity company belonging to Votorantim Group.[1] The company is based in São Paulo, Brazil and currently has investments in eight companies: Amyris Biotech, Anfreixo, Base Metals, Moksha8, Nitro Química, Quadrem and SAM.
The company invests in companies in early stage of development with high growth potential and also in more mature businesses, where value creation stems from the renewal of the operating model or business.[2][3]
VNN has experience in business structuring, mergers and acquisitions, practice in strategic management, financial, operational and human resources and expertise of business sectors such as life sciences, technology services and mineral exploration.[citation needed]
References[edit]
- ^ "Votorantim Novos Negocios - VNN is a venture capital and private equity firm. | Startup Ranking". StartupRanking. Retrieved 2022-06-07.
- ^ "Votorantim Novos Negocios Ltda. Company Profile - Brazil | Contacts & Key Executives | EMIS". www.emis.com. Retrieved 2022-06-07.
- ^ "Votorantim busca crescer em novos negócios e em países de moeda forte". Valor Econômico (in Brazilian Portuguese). Retrieved 2022-06-07.